Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy
British Journal of Cancer - United Kingdom
doi 10.1038/s41416-018-0229-0
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Springer Science and Business Media LLC